AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
Daratumumab in Tunisia
2 products registered with DPM — 0 active, 2 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DARZALEX Solution à diluer pour perfusion / 20mg/ml | 15273061H | Janssen-Cilag International N.V | expired | 19 Oct 2021 |
| DARZALEX Solution à diluer pour perfusion / 20mg/ml | 15273062H | Janssen-Cilag International N.V | expired | 19 Oct 2021 |
Daratumumab — DPM Registration Details
DPM (Tunisia) has 2 registered products containing Daratumumab, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track Daratumumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.